Induction of Covalently Crosslinked p62 Oligomers with Reduced Binding to Polyubiquitinated Proteins by the Autophagy Inhibitor Verteporfin
Open Access
- 10 December 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (12) , e114964
Abstract
Autophagy is a cellular catabolic process responsible for the degradation of cytoplasmic constituents, including organelles and long-lived proteins, that helps maintain cellular homeostasis and protect against various cellular stresses. Verteporfin is a benzoporphyrin derivative used clinically in photodynamic therapy to treat macular degeneration. Verteporfin was recently found to inhibit autophagosome formation by an unknown mechanism that does not require exposure to light. We report that verteporfin directly targets and modifies p62, a scaffold and adaptor protein that binds both polyubiquitinated proteins destined for degradation and LC3 on autophagosomal membranes. Western blotting experiments revealed that exposure of cells or purified p62 to verteporfin causes the formation of covalently crosslinked p62 oligomers by a mechanism involving low-level singlet oxygen production. Rose bengal, a singlet oxygen producer structurally unrelated to verteporfin, also produced crosslinked p62 oligomers and inhibited autophagosome formation. Co-immunoprecipitation experiments demonstrated that crosslinked p62 oligomers retain their ability to bind to LC3 but show defective binding to polyubiquitinated proteins. Mutations in the p62 PB1 domain that abolish self-oligomerization also abolished crosslinked oligomer formation. Interestingly, small amounts of crosslinked p62 oligomers were detected in untreated cells, and other groups noted the accumulation of p62 forms with reduced SDS-PAGE mobility in cellular and animal models of oxidative stress and aging. These data indicate that p62 is particularly susceptible to oxidative crosslinking and lead us to propose a model whereby oxidized crosslinked p62 oligomers generated rapidly by drugs like verteporfin or over time during the aging process interfere with autophagy.Keywords
This publication has 105 references indexed in Scilit:
- Autophagosomes form at ER–mitochondria contact sitesNature, 2013
- Keap1 degradation by autophagy for the maintenance of redox homeostasisProceedings of the National Academy of Sciences, 2012
- Inhibition of Autophagosome Formation by the Benzoporphyrin Derivative VerteporfinJournal of Biological Chemistry, 2011
- Mitochondria Supply Membranes for Autophagosome Biogenesis during StarvationCell, 2010
- A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formationNature Cell Biology, 2009
- Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3The EMBO Journal, 2009
- Autophagy in aging, disease and death: the true identity of a cell death impostorCell Death & Differentiation, 2008
- PCNA damage caused by antineoplastic drugsBiochemical Pharmacology, 2008
- Suppression of basal autophagy in neural cells causes neurodegenerative disease in miceNature, 2006
- Loss of autophagy in the central nervous system causes neurodegeneration in miceNature, 2006